Author:
Bokhari S W,Watson L,Nagra S,Cook M,Byrne J L,Craddock C,Russell N H
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference24 articles.
1. Farag SS, Archer KJ, Mrózek K, Ruppert AS, Carroll AJ, Vardiman JW et al. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 846. Blood 2006; 108: 63–73.
2. Craig CM, Schiller GJ . Acute myeloid leukemia in the elderly conventional and novel treatment approaches. Blood Rev 2008; 22: 221–234.
3. Dombret H, Raffoux E, Gardin C . Acute myeloid leukemia in the elderly. Semin Oncol 2008; 35: 430–438.
4. Burnett AK, Wheatley K, Goldstone AH, Stevens RF, Hann IM, Rees JF et al. MRC AML12: a comparison of ADE vs MAE and S-DAT vs H-DAT ± retinoic acid for induction and four vs five total courses using chemotherapy or stem cell transplant in consolidation, in 3459 patients under 60 years with AML [abstract]. Blood 2002; 100: 155a.
5. Goldstone AH, Burnett AK, Wheatley K, Smith AG, Hutchinson RM, Clark RE et al. Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial. Blood 2001; 98: 1302–1311.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献